Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 17NIH 4NETWORK 3OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Sarcoma 19Fibrosarcoma 8Leiomyosarcoma 7Sarcoma, Synovial 6Rhabdomyosarcoma 6Neurofibrosarcoma 6Lymphoma 6Liposarcoma 6Histiocytoma, Malignant Fibrous 6Hemangiosarcoma 6Osteosarcoma 5Neuroectodermal Tumors, Primitive, Peripheral 5Malignant mesenchymal tumor 5Hemangiopericytoma, Malignant 5Burkitt Lymphoma 4Testicular Neoplasms 3Teratoma 3Sarcoma, Ewing 3Sarcoma, Alveolar Soft Part 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Ovarian Neoplasms 3Lymphoma, Large B-Cell, Diffuse 3Hodgkin Disease 3Carcinoma, Embryonal 3Wilms Tumor 2Sarcoma, Endometrial Stromal 2Pheochromocytoma 2Neuroblastoma 2Neoplasm Metastasis 2Leukemia 2

Interventions

Doxorubicin 13Bleomycin 12Vinblastine 11Prednisone 11Vincristine 10Etoposide 10Cyclophosphamide 10Radiotherapy 9Filgrastim 9Dacarbazine 7Procarbazine 6Granulocyte Colony-Stimulating Factor 5Dexamethasone 5ABVD protocol 5Vinorelbine 4Peripheral Blood Stem Cell Transplantation 4Melphalan 4Gemcitabine 4Cytarabine 4Cisplatin 4Carmustine 4etoposide phosphate 3Mechlorethamine 3Ifosfamide 3indolepropanol phosphate 2Whole-Body Irradiation 2Positron Emission Tomography Computed Tomography 2Polymerase Chain Reaction 2Podophyllotoxin 2Nivolumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Hodgkin Disease × Ifosfamide × Clear all
NCT01026220 2022-04-28

Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma

Children's Oncology Group

Phase 3 Completed
166 enrolled 14 charts
Lymphoid

Hodgkin Disease

NCT00302003 2021-03-30

Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma

Children's Oncology Group

Phase 3 Completed
287 enrolled 12 charts
Lymphoid

Hodgkin Disease

NCT00006760 2013-07-26

Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma

Children's Oncology Group

Phase 2 Completed
66 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡